Oryzon Genomics Announces Listing on Madrid Stock Exchange
Company valued at approximately EUR 100 million Priced at EUR 3.39 per share Founders, Carlos Buesa and Tamara Maes, control 26.3% of shares outstanding BARCELONA, Spain and CAMBRIDGE, Mass., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Oryzon Genomics, a …